US2022143201A1PendingUtilityA1

Composition comprising a polymeric reagent

Assignee: NEKTAR THERAPEUTICSPriority: Jun 16, 2005Filed: Jan 27, 2022Published: May 12, 2022
Est. expiryJun 16, 2025(expired)· nominal 20-yr term from priority
C07D 207/46A61K 31/765C07K 14/575A61K 47/60C08G 65/338C08G 61/02A61K 38/26A61K 47/30C07C 235/68C08K 2201/012C08G 65/33396A61P 3/10C08G 65/48A61K 38/28A61K 47/50C08G 65/3348C08K 5/13
81
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates. The conjugates as well as the polymeric reagents used to form the conjugates include at least one of each the following: an aromatic moiety comprising an ionizable hydrogen atom, a spacer moiety, and a water-soluble polymer. Methods of making polymeric reagents and conjugates, as well as methods for administering conjugates and compositions, are also provided.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A polymeric reagent of Formula I: 
       
         
           
           
               
               
           
         
       
       wherein:
 POLY 1  is a first water-soluble polymer; 
 POLY 2  is a second water-soluble polymer; 
 X 1  is a first spacer moiety; 
 X 2  is a second spacer moiety; 
 
       
         
           
           
               
               
           
         
         is an aromatic-containing moiety bearing an ionizable hydrogen atom, H α ; 
         R 1  is H or an organic radical; 
         R 2  is H or an organic radical; 
         (a) is either zero or one; 
         (b) is either zero or one; 
         R e1 , when present, is a first electron altering group; 
         R e2 , when present, is a second electron altering group; and 
         (FG) is a functional group capable of reacting with an amino group of an active agent to form a degradable linkage. 
       
     
     
         2 . The polymeric reagent of  claim 1 , of Formula II: 
       
         
           
           
               
               
           
         
       
       wherein:
 POLY 1  is a first water-soluble polymer; 
 POLY 2  is a second water-soluble polymer; 
 X 1  is a first spacer moiety; 
 X 2  is a second spacer moiety; 
 Ar 1  is a first aromatic moiety; 
 Ar 2  is a second aromatic moiety; 
 H α  is an ionizable hydrogen atom; 
 R 1  is H or an organic radical; 
 R 2  is H or an organic radical; 
 (a) is either zero or one; 
 (b) is either zero or one; 
 R e1 , when present, is a first electron altering group; 
 R e2 , when present, is a second electron altering group; and 
 (FG) is a functional group capable of reacting with an amino group of an active agent to form a degradable linkage. 
 
     
     
         3 . The polymeric reagent of  claim 1 , of Formula III: 
       
         
           
           
               
               
           
         
       
       wherein:
 POLY 1  is a first water-soluble polymer; 
 POLY 2  is a second water-soluble polymer; 
 X 1  is a first spacer moiety; 
 X 2  is a second spacer moiety; 
 Ar 1  is a first aromatic moiety; 
 Ar 2  is a second aromatic moiety; 
 H α  is an ionizable hydrogen atom; 
 R 1  is H or an organic radical; 
 R 2  is H or an organic radical; 
 (a) is either zero or one; 
 (b) is either zero or one; 
 R e1 , when present, is a first electron altering group; 
 R e2 , when present, is a second electron altering group; and 
 (FG) is a functional group capable of reacting with an amino group of an active agent to form a degradable linkage. 
 
     
     
         4 . The polymeric reagent of  claim 1 , of Formula IV: 
       
         
           
           
               
               
           
         
       
       wherein:
 POLY 2  is a first water-soluble polymer; 
 POLY 2  is a second water-soluble polymer; 
 X 1  is a first spacer moiety; 
 X 2  is a second spacer moiety; 
 X 3  is a third spacer moiety; 
 Ar 1  is a first aromatic moiety; 
 Ar 2  is a second aromatic moiety; 
 H α  is an ionizable hydrogen atom; 
 R 1  is H or an organic radical; 
 R 2  is H or an organic radical; 
 (a) is either zero or one; 
 (b) is either zero or one; 
 R e1 , when present, is a first electron altering group; 
 R e2 , when present, is a second electron altering group; and 
 (FG) is a functional group capable of reacting with an amino group of an active agent to form a degradable linkage. 
 
     
     
         5 . The polymeric reagent of  claim 1 , of Formula V: 
       
         
           
           
               
               
           
         
       
       wherein:
 POLY 1  is a first water-soluble polymer; 
 POLY 2  is a second water-soluble polymer; 
 X 1  is a first spacer moiety; 
 X 2  is a second spacer moiety; 
 H α  is an ionizable hydrogen atom; 
 R 1  is H or an organic radical; 
 R 2  is H or an organic radical; 
 (a) is either zero or one; 
 (b) is either zero or one; 
 R e1 , when present, is a first electron altering group; 
 R e2 , when present, is a second electron altering group; and 
 (FG) is a functional group capable of reacting with an amino group of an active agent to form a degradable linkage. 
 
     
     
         6 . A polymeric reagent of Formula VI: 
       
         
           
           
               
               
           
         
       
       wherein:
 POLY is a water-soluble polymer; 
 X is a spacer moiety that does not include a 
 
       
         
           
           
               
               
           
         
          moiety; 
       
       
         
           
           
               
               
           
         
         is an aromatic moiety bearing an ionizable hydrogen atom, H α ; 
         R 1  is H or an organic radical; 
         R 2  is H or an organic radical; 
         (a) is either zero or one; 
         R e , when present, is an electron altering group; and 
         (FG) is a functional group capable of reacting with an amino group of an active agent to form a degradable linkage. 
       
     
     
         7 . The polymeric reagent of  claim 6 , wherein 
       
         
           
           
               
               
           
         
       
     
     
         8 . The polymeric reagent as in any one of  claims 1 ,  2 ,  3 ,  4  and  5 , wherein each of POLY 1  and POLY 2  is a poly(ethylene glycol). 
     
     
         9 . The polymeric reagent of  claim 6 , wherein POLY is a poly(ethylene glycol). 
     
     
         10 . The polymeric reagent as in any one of  claims 1 ,  2 ,  3 ,  4  and  5 , wherein each poly(ethylene glycol) has a weight-average molecular weight in the range of from about 120 Daltons to about 6,000 Daltons. 
     
     
         11 . The polymeric reagent of  claim 6 , wherein the poly(ethylene glycol) has a weight-average molecular weight in the range of from about 120 Daltons to about 6,000 Daltons. 
     
     
         12 . The polymeric reagent as in any one of  claims 1 ,  2 ,  3 ,  4  and  5 , wherein each poly(ethylene glycol) has a weight-average molecular weight in the range of from about 6,000 Daltons to about 100,000 Daltons. 
     
     
         13 . The polymeric reagent of  claim 6 , wherein the poly(ethylene glycol) has a weight-average molecular weight in the range of from about 6,000 Daltons to about 100,000 Daltons. 
     
     
         14 . The polymeric reagent as in any one of  claims 1 ,  2 ,  3 ,  4  and  5 , wherein the first spacer moiety is selected from the group consisting
 of —C(O)—NH—CH 2 —CH 2 —, —CH 2 —CH 2 —NH—C(O)—, —C(O)—NH—CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —NH—C(O)—, —C(O)—NH—CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —NH—C(O)—, —C(O)—NH—, —NH—C(O)—, —C(O)—NH—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —NH—C(O)—, —NH—C(O)—CH 2 —CH 2 —, —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—NH—, —C(O)—CH 2 —CH 2 —, —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —NH—CH 2 —CH 2 —(OCH 2 CH 2 ) 1-3 —NH—C(O)—, —C(O)—NH—(CH 2 CH 2 O) 1-3 —CH 2 —CH 2 —NH—, —C(O)—NH—CH 2 —CH 2 —(OCH 2 CH 2 ) 1-3 —NH—C(O)—, —C(O)—NH—(CH 2 CH 2 O) 1-3 —CH 2 —CH 2 —NH—C(O)—, —NH—C(O)—CH 2 —, —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —O—, —O—CH 2 —C(O)—NH—, —CH 2 —CH 2 —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—CH 2 —CH 2 —, —O—CH 2 —CH 2 —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—CH 2 —CH 2 —O—, —C(O)—NH—CH 2 —CH 2 —, —CH 2 —CH 2 —NH—C(O)—, —C(O)—NH—CH 2 —CH 2 —O—, and —O—CH 2 —CH 2 —NH—C(O)—, and the second spacer moiety is selected from the group consisting 
 of —C(O)—NH—CH 2 —CH 2 —, —CH 2 —CH 2 —NH—C(O)—, —C(O)—NH—CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —NH—C(O)—, —C(O)—NH—CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —NH—C(O)—, —C(O)—NH—, —NH—C(O)—, —C(O)—NH—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —NH—C(O)—, —NH—C(O)—CH 2 —CH 2 —, —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—NH—, —C(O)—CH 2 —CH 2 —, —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —NH—CH 2 —CH 2 —(OCH 2 CH 2 ) 1-3 —NH—C(O)—, —C(O)—NH—(CH 2 CH 2 O) 1-3 —CH 2 —CH 2 —NH—, —C(O)—NH—CH 2 —CH 2 —(OCH 2 CH 2 ) 1-3 —NH—C(O)—, —C(O)—NH—(CH 2 CH 2 O) 1-3 —CH 2 —CH 2 —NH—C(O)—, —NH—C(O)—CH 2 —, —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —O—, —O—CH 2 —C(O)—NH—, —CH 2 —CH 2 —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—CH 2 —CH 2 —, —O—CH 2 —CH 2 —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—CH 2 —CH 2 —O—, —C(O)—NH—CH 2 —CH 2 —, —CH 2 —CH 2 —NH—C(O)—, —C(O)—NH—CH 2 —CH 2 —O—, and —O—CH 2 —CH 2 —NH—C(O)—. 
 
     
     
         15 . The polymeric reagent as in any one of  claims 1 ,  2 ,  3 ,  4 ,  5  and  6 , wherein R 1  is H and R 2  is H. 
     
     
         16 . The polymeric reagent as in any one of  claims 1 ,  2 ,  3 ,  4 ,  5  and  6 , wherein the functional group capable of reacting with an amino group of an active agent is selected from the group consisting of carbonates of N-succinimidyl, 1-benzotriazolyl, imidazole, imidazole, halides and phenolates. 
     
     
         17 . The polymeric reagent as in any one of  claims 1 ,  2 ,  3 ,  4 ,  5  and  6 , wherein the functional group capable of reacting with an amino group is a carbonate of N-succinimidyl. 
     
     
         18 . The polymeric reagent as in any one of  claims 1 ,  2 ,  3 ,  4  and  5 , wherein (a) is zero and (b) is zero. 
     
     
         19 . The polymeric reagent of  claim 6 , wherein (a) is zero. 
     
     
         20 . The polymeric reagent as in any one of  claims 1 ,  2 ,  3 ,  4  and  5 , wherein (a) is one, (b) is zero, and the first electron altering group is selected from the group consisting of halo, lower alkyl, aryl, substituted aryl, substituted arylakyl, alkoxy, aryloxy, alkylthio, arylthio, CF 3 , —CH 2 CF 3 , —CH 2 C 6 F 5 , —CN, —NO 2 , —S(O)R, —S(O)Ar, —S(O 2 )R, —S(O 2 )Ar, —S(O 2 )OR, —S(O 2 )OAr, —S(O 2 )NHR, —S(O 2 )NHAr, —C(O)R, —C(O)Ar, —C(O)OR, and —C(O)NHR, wherein Ar is aryl and R is H or an organic radical. 
     
     
         21 . The polymeric reagent of  claim 6 , wherein (a) is one and the electron altering group is selected from the group consisting of halo, lower alkyl, aryl, substituted aryl, substituted arylakyl, alkoxy, aryloxy, alkylthio, arylthio, CF 3 , —CH 2 CF 3 , —CH 2 C 6 F 5 , —CN, —NO 2 , —S(O)R, —S(O)Ar, —S(O 2 )R, —S(O 2 )Ar, —S(O 2 )OR, —S(O 2 )OAr, —S(O 2 )NHR, —S(O 2 )NHAr, —C(O)R, —C(O)Ar, —C(O)OR, and —C(O)NHR, wherein Ar is aryl and R is H or an organic radical. 
     
     
         22 . The polymeric reagent of  claim 5 , selected from the group consisting of 
       
         
           
           
               
               
           
         
       
       wherein, for each structure, each (n) is from 4 to 1500. 
     
     
         23 . The polymeric reagent of  claim 5 , of the formula: 
       
         
           
           
               
               
           
         
       
       wherein each (n) is from 4 to 1500. 
     
     
         24 . The polymeric reagent of  claim 5 , of the formula: 
       
         
           
           
               
               
           
         
       
       wherein each (n) is from 4 to 1500. 
     
     
         25 . The polymeric reagent of  claim 5 , of the formula: 
       
         
           
           
               
               
           
         
       
       wherein each (n) is from 4 to 1500. 
     
     
         26 . The polymeric reagent of  claim 5 , of the formula: 
       
         
           
           
               
               
           
         
       
       wherein each (n) is from 4 to 1500. 
     
     
         27 . The polymeric reagent of  claim 5 , of the formula: 
       
         
           
           
               
               
           
         
       
       wherein each (n) is from 4 to 1500. 
     
     
         28 . The polymeric reagent of  claim 5 , of the formula: 
       
         
           
           
               
               
           
         
       
       wherein each (n) is from 4 to 1500. 
     
     
         29 . The polymeric reagent of  claim 6 , of the formula: 
       
         
           
           
               
               
           
         
       
       wherein (n) is from 4 to 1500. 
     
     
         30 . A conjugate of Formula I-C: 
       
         
           
           
               
               
           
         
       
       wherein:
 POLY 1  is a first water-soluble polymer; 
 POLY 2  is a second water-soluble polymer; 
 X 1  is a first spacer moiety; 
 X 2  is a second spacer moiety; 
 
       
         
           
           
               
               
           
         
         is an aromatic-containing moiety bearing an ionizable hydrogen atom, H α ; 
         R 1  is H or an organic radical; 
         R 2  is H or an organic radical; 
         (a) is either zero or one; 
         (b) is either zero or one; 
         R e1 , when present, is a first electron altering group; 
         R e2 , when present, is a second electron altering group; 
         Y 1  is O or S; 
         Y 2  is O or S; and 
         D is a residue of a biologically active agent. 
       
     
     
         31 . The conjugate of  claim 30 , of Formula II-C: 
       
         
           
           
               
               
           
         
       
       wherein:
 POLY 1  is a first water-soluble polymer; 
 POLY 2  is a second water-soluble polymer; 
 X 1  is a first spacer moiety; 
 X 2  is a second spacer moiety; 
 Ar 1  is a first aromatic moiety; 
 Ar 2  is a second aromatic moiety; 
 H α  is an ionizable hydrogen atom; 
 R 1  is H or an organic radical; 
 R 2  is H or an organic radical; 
 (a) is either zero or one; 
 (b) is either zero or one; 
 R e1 , when present, is a first electron altering group; 
 R e2 , when present, is a second electron altering group; 
 Y 1  is O or S; 
 Y 2  is O or S; and 
 D is a residue of a biologically active agent. 
 
     
     
         32 . The conjugate of  claim 30 , of Formula III-C: 
       
         
           
           
               
               
           
         
       
       wherein:
 POLY 1  is a first water-soluble polymer; 
 POLY 2  is a second water-soluble polymer; 
 X 1  is a first spacer moiety; 
 X 2  is a second spacer moiety; 
 Ar 1  is a first aromatic moiety; 
 Ar 2  is a second aromatic moiety; 
 H α  is an ionizable hydrogen atom; 
 R 1  is H or an organic radical; 
 R 2  is H or an organic radical; 
 (a) is either zero or one; 
 (b) is either zero or one; 
 R e1 , when present, is a first electron altering group; 
 R e2 , when present, is a second electron altering group; 
 Y 1  is O or S; 
 Y 2  is O or S; and 
 D is a residue of a biologically active agent. 
 
     
     
         33 . The conjugate of  claim 30 , of Formula IV-C: 
       
         
           
           
               
               
           
         
       
       wherein:
 POLY 1  is a first water-soluble polymer; 
 POLY 2  is a second water-soluble polymer; 
 X 1  is a first spacer moiety; 
 X 2  is a second spacer moiety; 
 X 3  is a third spacer moiety; 
 Ar 1  is a first aromatic moiety; 
 Ar 2  is a second aromatic moiety; 
 H α  is an ionizable hydrogen atom; 
 R 1  is H or an organic radical; 
 R 2  is H or an organic radical; 
 (a) is either zero or one; 
 (b) is either zero or one; 
 R e1 , when present, is a first electron altering group; 
 R e2 , when present, is a second electron altering group; 
 Y 1  is O or S; 
 Y 2  is O or S; and 
 D is a residue of a biologically active agent. 
 
     
     
         34 . The conjugate of  claim 30 , of Formula V-C: 
       
         
           
           
               
               
           
         
         POLY 1  is a first water-soluble polymer; 
         POLY 2  is a second water-soluble polymer; 
         X 1  is a first spacer moiety; 
         X 2  is a second spacer moiety; 
         H α  is an ionizable hydrogen atom; 
         R 1  is H or an organic radical; 
         R 2  is H or an organic radical; 
         (a) is either zero or one; 
         (b) is either zero or one; 
         R e1 , when present, is a first electron altering group; 
         R e2 , when present, is a second electron altering group; and 
         Y 1  is O or S; 
         Y 2  is O or S; and 
         D is a residue of a biologically active agent. 
       
     
     
         35 . A conjugate of Formula VI-C: 
       
         
           
           
               
               
           
         
       
       wherein:
 POLY is a water-soluble polymer; 
 X is a spacer moiety that does not include a 
 
       
         
           
           
               
               
           
         
          moiety; 
       
       
         
           
           
               
               
           
         
         is an aromatic-containing moiety bearing an ionizable hydrogen atom, H α ; 
         R 1  is H or an organic radical; 
         R 2  is H or an organic radical; 
         (a) is either zero or one; 
         R e , when present, is an electron altering group; 
         Y 1  is O or S; 
         Y 2  is O or S; and 
         D is a residue of a biologically active agent. 
       
     
     
         36 . The polymeric reagent of  claim 35 , wherein 
       
         
           
           
               
               
           
         
       
     
     
         37 . The conjugate as in any one of  claims 30 ,  31 ,  32 ,  33  and  34 , wherein each of POLY 1  and POLY 2  is a poly(ethylene glycol). 
     
     
         38 . The conjugate of  claim 35 , wherein POLY is a poly(ethylene glycol). 
     
     
         39 . The conjugate as in any one of  claims 30 ,  31 ,  32 ,  33  and  34 , wherein each poly(ethylene glycol) has a weight-average molecular weight in the range of from about 120 Daltons to about 6,000 Daltons. 
     
     
         40 . The conjugate of  claim 35 , wherein the poly(ethylene glycol) has a weight-average molecular weight in the range of from about 120 Daltons to about 6,000 Daltons. 
     
     
         41 . The conjugate as in any one of  claims 30 ,  31 ,  32 ,  33  and  34 , wherein each poly(ethylene glycol) has a weight-average molecular weight in the range of from about 6,000 Daltons to about 100,000 Daltons. 
     
     
         42 . The conjugate of  claim 35 , wherein the poly(ethylene glycol) has a weight-average molecular weight in the range of from about 6,000 Daltons to about 100,000 Daltons. 
     
     
         43 . The conjugate as in any one of  claims 30 ,  31 ,  32 ,  33  and  34 , wherein the first spacer moiety is selected from the group consisting
 of —C(O)—NH—CH 2 —CH 2 —, —CH 2 —CH 2 —NH—C(O)—, —C(O)—NH—CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —NH—C(O)—, —C(O)—NH—CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —NH—C(O)—, —C(O)—NH—, —NH—C(O)—, —C(O)—NH—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —NH—C(O)—, —NH—C(O)—CH 2 —CH 2 —, —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—NH—, —C(O)—CH 2 —CH 2 —, —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —NH—CH 2 —CH 2 —(OCH 2 CH 2 ) 1-3 —NH—C(O)—, —C(O)—NH—(CH 2 CH 2 O) 1-3 —CH 2 —CH 2 —NH—, —C(O)—NH—CH 2 —CH 2 —(OCH 2 CH 2 ) 1-3 —NH—C(O)—, —C(O)—NH—(CH 2 CH 2 O) 1-3 —CH 2 —CH 2 —NH—C(O)—, —NH—C(O)—CH 2 —, —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —O—, —O—CH 2 —C(O)—NH—, —CH 2 —CH 2 —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—CH 2 —CH 2 —, —O—CH 2 —CH 2 —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—CH 2 —CH 2 —O—, —C(O)—NH—CH 2 —CH 2 —, —CH 2 —CH 2 —NH—C(O)—, —C(O)—NH—CH 2 —CH 2 —O—, and —O—CH 2 —CH 2 —NH—C(O)—, and the second spacer moiety is selected from the group consisting 
 of —C(O)—NH—CH 2 —CH 2 —, —CH 2 —CH 2 —NH—C(O)—, —C(O)—NH—CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —NH—C(O)—, —C(O)—NH—CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —NH—C(O)—, —C(O)—NH—, —NH—C(O)—, —C(O)—NH—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —NH—C(O)—, —NH—C(O)—CH 2 —CH 2 —, —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—NH—, —C(O)—CH 2 —CH 2 —, —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —, —CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —NH—CH 2 —CH 2 —(OCH 2 CH 2 ) 1-3 —NH—C(O)—, —C(O)—NH—(CH 2 CH 2 O) 1-3 —CH 2 —CH 2 —NH—, —C(O)—NH—CH 2 —CH 2 —(OCH 2 CH 2 ) 1-3 —NH—C(O)—, —C(O)—NH—(CH 2 CH 2 O) 1-3 —CH 2 —CH 2 —NH—C(O)—, —NH—C(O)—CH 2 —, —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —O—, —O—CH 2 —C(O)—NH—, —CH 2 —CH 2 —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—CH 2 —CH 2 —, —O—CH 2 —CH 2 —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—, —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—CH 2 —CH 2 —O—, —C(O)—NH—CH 2 —CH 2 —, —CH 2 —CH 2 —NH—C(O)—, —C(O)—NH—CH 2 —CH 2 —O—, and —O—CH 2 —CH 2 —NH—C(O)—. 
 
     
     
         44 . The conjugate as in any one of  claims 1 ,  2 ,  3 ,  4 ,  5  and  6 , wherein R 1  is H and R 2  is H. 
     
     
         45 . The conjugate as in any one of  claims 30 ,  31 ,  32 ,  33 ,  34  and  35 , wherein Y 1  is O and Y 2  is O. 
     
     
         46 . The conjugate as in any one of  claims 30 ,  31 ,  32 ,  33 ,  34  and  35 , wherein the biologically active agent is a polypeptide. 
     
     
         47 . The conjugate as in any one of  claims 30 ,  31 ,  32 ,  33  and  34  wherein (a) is zero and (b) is zero. 
     
     
         48 . The conjugate of  claim 35 , wherein (a) is zero. 
     
     
         49 . The conjugate as in any one of  claims 30 ,  31 ,  32 ,  33  and  34 , wherein (a) is one, (b) is zero, and the first electron altering group is selected from the group consisting of halo, lower alkyl, aryl, substituted aryl, substituted arylakyl, alkoxy, aryloxy, alkylthio, arylthio, CF 3 , —CH 2 CF 3 , —CH 2 C 6 F 5 , —CN, —NO 2 , —S(O)R, —S(O)Ar, —S(O 2 )R, —S(O 2 )Ar, —S(O 2 )OR, —S(O 2 )OAr, —S(O 2 )NHR, —S(O 2 )NHAr, —C(O)R, —C(O)Ar, —C(O)OR, and —C(O)NHR, wherein Ar is aryl and R is H or an organic radical. 
     
     
         50 . The conjugate of  claim 35 , wherein (a) is one and the electron altering group is selected from the group consisting of halo, lower alkyl, aryl, substituted aryl, substituted arylakyl, alkoxy, aryloxy, alkylthio, arylthio, CF 3 , —CH 2 CF 3 , —CH 2 C 6 F 5 , —CN, —NO 2 , —S(O)R, —S(O)Ar, —S(O 2 )R, —S(O 2 )Ar, —S(O 2 )OR, —S(O 2 )OAr, —S(O 2 )NHR, —S(O 2 )NHAr, —C(O)R, —C(O)Ar, —C(O)OR, and —C(O)NHR, wherein Ar is aryl and R is H or an organic radical. 
     
     
         51 . The conjugate of  claim 1 , selected from the group consisting of: 
       
         
           
           
               
               
           
         
       
       wherein, for each structure, each (n) is from 4 to 1500 and D is a residue of a biologically active agent. 
     
     
         52 . The conjugate of  claim 30 , of the formula: 
       
         
           
           
               
               
           
         
       
       wherein each (n) is from 4 to 1500 and D is a residue of a biologically active agent. 
     
     
         53 . The conjugate of  claim 30 , of the formula: 
       
         
           
           
               
               
           
         
       
       wherein each (n) is from 4 to 1500 and D is a residue of a biologically active agent. 
     
     
         54 . The conjugate of  claim 30 , of the formula: 
       
         
           
           
               
               
           
         
       
       wherein each (n) is from 4 to 1500 and D is a residue of a biologically active agent. 
     
     
         55 . The conjugate of  claim 30 , of the formula: 
       
         
           
           
               
               
           
         
       
       wherein each (n) is from 4 to 1500 and D is a residue of a biologically active agent. 
     
     
         56 . The conjugate of  claim 30 , of the formula: 
       
         
           
           
               
               
           
         
       
       wherein each (n) is from 4 to 1500 and D is a residue of a biologically active agent. 
     
     
         57 . The conjugate of  claim 30 , of the formula: 
       
         
           
           
               
               
           
         
       
       wherein each (n) is from 4 to 1500 and D is a residue of a biologically active agent. 
     
     
         58 . The conjugate of  claim 35 , of the formula: 
       
         
           
           
               
               
           
         
       
       wherein (n) is from 4 to 1500 and D is a residue of a biologically active agent. 
     
     
         59 . A method for preparing a polymeric reagent, comprising:
 (a) providing an aromatic moiety bearing a first attachment site, a second attachment site   
       and a third attachment site;
 (b) reacting a functional group reagent with the first attachment site to result in the first attachment site bearing a functional group capable of reacting with an amino group of an active agent and resulting in a hydolyzable carbamate; 
 (c) reacting a plurality of water-soluble polymers bearing a reactive group with the second attachment site and third attachment site to result in (i) the second attachment site bearing a water-soluble polymer through a spacer moiety, and (ii) the third attachment site bearing a second water-soluble polymer through a spacer moiety. 
 
     
     
         60 . The method of  claim 59 , wherein step (b) is performed before step (c). 
     
     
         61 . The method of  claim 59 , wherein step (c) is performed before step (b). 
     
     
         62 . A method for preparing a conjugate, comprising reacting under conjugation conditions a polymeric reagent according to any one of  claims 1 ,  2 ,  3 ,  4 ,  5  or  6  with an amine-containing biologically active agent. 
     
     
         63 . A conjugate prepared by the method of  claim 62 . 
     
     
         64 . A pharmaceutical composition comprising a conjugate of  claim 63  and a pharmaceutically acceptable excipient. 
     
     
         65 . The pharmaceutical composition of  claim 64 , in lyophilized form. 
     
     
         66 . The pharmaceutical composition of  claim 64 , further comprising a liquid diluent. 
     
     
         67 . The pharmaceutical composition of  claim 66 , wherein the liquid diluent is selected from the group consisting of bacteriostatic water for injection, dextrose 5% in water, phosphate-buffered saline, Ringer's solution, saline solution, sterile water, deionized water, and combinations thereof. 
     
     
         68 . The pharmaceutical composition of  claim 64 , in unit dosage form. 
     
     
         69 . The pharmaceutical composition of  claim 68 , housed in a glass vial. 
     
     
         70 . A method of delivering a conjugate comprising the step of administering to a patient a therapeutically effective amount of a conjugate according to any one of  claims 30 ,  31 ,  32 ,  33 ,  34  and  35 .

Join the waitlist — get patent alerts

Track US2022143201A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.